127 related articles for article (PubMed ID: 7956268)
1. Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group.
Henzlova MJ; Blackburn GH; Bradley EJ; Rogers WJ
Control Clin Trials; 1994 Aug; 15(4):284-93. PubMed ID: 7956268
[TBL] [Abstract][Full Text] [Related]
2. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.
Rogers WJ; Johnstone DE; Yusuf S; Weiner DH; Gallagher P; Bittner VA; Ahn S; Schron E; Shumaker SA; Sheffield LT
J Am Coll Cardiol; 1994 Feb; 23(2):393-400. PubMed ID: 8294693
[TBL] [Abstract][Full Text] [Related]
3. Results of the treatment trial of the studies of left ventricular dysfunction (SOLVD). The SOLVD Investigators.
Pouleur H
Am J Cardiol; 1992 Oct; 70(10):135C-136C. PubMed ID: 1414890
[No Abstract] [Full Text] [Related]
4. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
[TBL] [Abstract][Full Text] [Related]
5. Recruitment strategies in the studies of left ventricular dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but separate trials. The SOLVD Investigators.
Carew BD; Ahn SA; Boichot HD; Dierenfeldt BJ; Dolan NA; Edens TR; Weiner DH; Probstfield JL
Control Clin Trials; 1992 Oct; 13(5):325-38. PubMed ID: 1330437
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
[TBL] [Abstract][Full Text] [Related]
7. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
8. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators.
Hayashida W; Van Eyll C; Rousseau MF; Pouleur H
J Am Coll Cardiol; 1993 Nov; 22(5):1403-10. PubMed ID: 8227798
[TBL] [Abstract][Full Text] [Related]
9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
[TBL] [Abstract][Full Text] [Related]
10. Progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. The Studies of Left Ventricular Dysfunction.
Melin JA; Konstam MA; Rousseau MF; Pouleur H
Ann Ital Med Int; 1993 Oct; 8 Suppl():9S. PubMed ID: 8117528
[No Abstract] [Full Text] [Related]
11. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD).
Johnstone D; Limacher M; Rousseau M; Liang CS; Ekelund L; Herman M; Stewart D; Guillotte M; Bjerken G; Gaasch W
Am J Cardiol; 1992 Oct; 70(9):894-900. PubMed ID: 1529944
[TBL] [Abstract][Full Text] [Related]
12. Congestive heart failure: new therapeutic strategies.
Pitt B
Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
[TBL] [Abstract][Full Text] [Related]
13. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
Jong P; Yusuf S; Rousseau MF; Ahn SA; Bangdiwala SI
Lancet; 2003 May; 361(9372):1843-8. PubMed ID: 12788569
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
Al-Khadra AS; Salem DN; Rand WM; Udelson JE; Smith JJ; Konstam MA
J Am Coll Cardiol; 1998 Feb; 31(2):419-25. PubMed ID: 9462588
[TBL] [Abstract][Full Text] [Related]
16. Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction.
Am J Cardiol; 1990 Aug; 66(3):315-22. PubMed ID: 2195865
[TBL] [Abstract][Full Text] [Related]
17. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.
Pouleur HG; Konstam MA; Udelson JE; Rousseau MF
J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):43A-48A. PubMed ID: 8376696
[TBL] [Abstract][Full Text] [Related]
18. Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction.
Pitt B
J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):158A-161A. PubMed ID: 8376688
[TBL] [Abstract][Full Text] [Related]
19. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
Vermes E; Ducharme A; Bourassa MG; Lessard M; White M; Tardif JC;
Circulation; 2003 Mar; 107(9):1291-6. PubMed ID: 12628950
[TBL] [Abstract][Full Text] [Related]
20. Clinical heart failure trials and the design rationale of Studies of Left Ventricular Dysfunction (SOLVD).
Young JB
J Hypertens Suppl; 1991 Dec; 9(2):S57-60; discussion S60-1. PubMed ID: 1791485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
